In 2012, Fresenius Kabi acquired Fenwal Inc., expanding Fresenius Kabi’s product offerings in the United States to include Fenwal products for transfusion medicine. These include advanced medical technologies used in blood separation, collection, filtration, storage and transfusion. In the U.S. Fresenius Kabi also offers a broad portfolio of specialty and generic pharmaceuticals under the APP brand (www.APPpharma.com). Our roots go back more than 100 years to the founding of our parent company, Fresenius SE, in Bad Homburg, Germany, where the company is headquartered today.
Serving health care is both an honor and a great responsibility. Our products are essential to health care, and our work will only become more important as the population continues to age. We are a great company that relies on great people to succeed. If you’d like to learn more about us, we’d love to hear from you.